Cytokinetics | CYTK - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Amgen USD 2.08B 570M 2026-03
Arca Biopharma USD -31.82M 2.24M 2026-03
Bayer EUR 2.99B 6.36B 2026-03
Biogen USD 647.3M 269.6M 2026-06
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Eisai JPY 25.28B 33.22B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 267.69M 15M 2026-03
Geron USD -3.64M 27.5M 2026-03
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
Ligand Pharmaceuticals USD -24.26M 81.04M 2026-03
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06